MedPath

Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.

Not Applicable
Recruiting
Conditions
Upper Gastrointestinal Bleeding
Interventions
Device: Endoscopic hemostasis using a Esophagogastroduodenoscopy
Registration Number
NCT06192355
Lead Sponsor
University Hospital Augsburg
Brief Summary

Controlled-randomized trial evaluating single-use versus reusable gastroscopes in patients with upper gastrointestinal bleeding.

Detailed Description

Acute upper gastrointestinal bleeding is a common medical emergency. According to guidelines, endoscopic evaluation should be performed within 24 hours. With an overall high incidence and an overall high number of diagnostic and therapeutic endoscopic procedures, the introduction of new endoscopic concepts may have a profound impact on outcomes as well as cost-effectiveness in upper gastrointestinal bleeding. For this purpose, the use of single-use gastroscopes represents an interesting possibility. Hygiene issues in the emergency situation are also relevant. The previous feasibility study One-Scope I demonstrated that the diagnosis as well as the therapy of upper gastrointestinal bleeding is possible with single-use gastroscopes. In this follow-up study, the investigators compare the use of single-use versus reusable gastroscopes in participants with suspected upper gastrointestinal bleeding in a randomized controlled trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Glasgow-Blatchford score (GBS) >2
  • Clinical signs of upper bleeding
Exclusion Criteria
  • pregnancy
  • Unable to provide consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single-use gastroscopeEndoscopic hemostasis using a EsophagogastroduodenoscopyA disposable endoscope designed for a one-time use during a Gastroscopy, eliminating the need for reprocessing or sterilization. After a single procedure, the entire gastroscope is discarded, reducing the risk of cross-contamination and ensuring a fresh, sterile instrument for each patient intervention
reusable gastroscopeEndoscopic hemostasis using a EsophagogastroduodenoscopyA durable endoscope designed for multiple uses after thorough reprocessing and sterilization
Primary Outcome Measures
NameTimeMethod
intraprocedural technical successUp to 20 minutes

defined as reaching the descending duodenum and adequately assessing for the presence of a bleeding site

Secondary Outcome Measures
NameTimeMethod
Length of interventionUp to 60 minutes

measured from initiation to achievement of hemostasis

blood transfusionsUp to 30 days

Need for blood transfusion due to a hemorrhage-related decrease in hemoglobin levels ≤ 70 g/L

re-bleeding rateUp to 30 days

need for further endoscopic, interventional-angiographic, or surgical intervention within 30 days due to upper GI-bleeding

Length of StayUp to 30 days

Duration of inpatient stay, measured from the day of admission to the day of discharge

intraprocedural clinical successUp to 45 Minutes

defined as successful endoscopic hemostasis during the examination if required

Adverse eventsUp to 30 days

Occurrence of adverse events, such as perforation, bleeding exacerbation, aspiration, and infection.

cross over to reusable gastroscopeUp to 60 Minutes

Switch to a reusable gastroscope in case of non-achieved technical or clinical success, such as unsuccessful hemostasis, insufficient assessment of the bleeding source, or inability to reach the descending duodenum

Trial Locations

Locations (1)

University Hospital of Augsburg

🇩🇪

Augsburg, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath